Enzalutamide is a medication used to treat advanced prostate cancer, specifically metastatic castration-resistant prostate cancer. It is an androgen receptor inhibitor, which means it works by blocking the effects of androgens (male hormones) on prostate cancer cells.
Each tablet of XTANDI, the brand name of enzalutamide, contains 40 mg of the active ingredient. It is used as a prostate cancer treatment in patients who have castration-resistant prostate cancer, which means their cancer has progressed despite medical or surgical treatments to lower testosterone levels.
https://www.chawlamedicos.com/....anticancer/enzalutam